🔎 Trials Near Me

Gara Jalqabaatti › Glioblastoma › North Carolina › Durham

Qorannoo klinikaalii Glioblastoma Durham, NC keessatti

Qorannoo 20 Glioblastoma f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Namoota walitti qabaa jiraSadarkaa 3
  • University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05902169

Targeted Pediatric High-Grade Glioma Therapy

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Duke University Health System, Durham
12 Months – 39 Years · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University Health System, Durham
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Namoota walitti qabaa jiraSadarkaa 3
  • Duke Cancer Institute, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Namoota walitti qabaa jiraSadarkaa 1
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT04903795

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06319027

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT05708352

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06069726

Lerapolturev (PVSRIPO) in GBM

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT06177964

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Namoota walitti qabaa jiraSadarkaa 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06805305

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
  • Duke University Health System, Durham
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06333899

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Namoota walitti qabaa jiraSadarkaa 1
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT04547777

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University Health System, Durham
12 Months – 39 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05843253

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Namoota walitti qabaa jiraSadarkaa 1
  • Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT05366179

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Duke University, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06625684

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Namoota walitti qabaa jiraSadarkaa 1
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Onk-2025 · NCT06455605

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Namoota walitti qabaa jiraSadarkaa 1/2
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Onk-2025 · NCT05734560

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Wax-2025 · NCT03175224

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Namoota walitti qabaa jiraSadarkaa 1
  • Duke University, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT05879367

Qorannoo Glioblastoma magaalota biroo keessatti

Qorannoo biroo Durham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.